Copy number and loss of heterozygosity detected by SNP array of formalin-fixed tissues using whole-genome amplification.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3180289)

Published in PLoS One on September 26, 2011

Authors

Angela Stokes1, Ignat Drozdov, Eliete Guerra, Christos A Ouzounis, Saman Warnakulasuriya, Michael J Gleeson, Mark McGurk, Mahvash Tavassoli, Edward W Odell

Author Affiliations

1: Department of Oral Pathology, King's College London Dental Institute, London, United Kingdom. angela.stokes@kcl.ac.uk

Articles cited by this

Lethality and centrality in protein networks. Nature (2001) 29.64

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55

Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet (2008) 15.89

Ensembl 2011. Nucleic Acids Res (2010) 14.68

Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci U S A (2002) 13.58

Network-based classification of breast cancer metastasis. Mol Syst Biol (2007) 12.18

Genomic analysis of regulatory network dynamics reveals large topological changes. Nature (2004) 9.32

The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. Nucleic Acids Res (2010) 4.58

Global topological features of cancer proteins in the human interactome. Bioinformatics (2006) 4.17

Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res (2004) 2.22

Quantifying uncertainty in genotype calls. Bioinformatics (2009) 1.74

Single nucleotide polymorphism array analysis of cancer. Curr Opin Oncol (2007) 1.66

Impact of whole genome amplification on analysis of copy number variants. Nucleic Acids Res (2008) 1.55

Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays. Cancer Res (2007) 1.25

The use of whole genome amplification in the study of human disease. Prog Biophys Mol Biol (2005) 1.22

Comparing whole-genome amplification methods and sources of biological samples for single-nucleotide polymorphism genotyping. Clin Chem (2005) 1.17

Whole genome SNP arrays using DNA derived from formalin-fixed, paraffin-embedded ovarian tumor tissue. Hum Mutat (2005) 1.15

Genome-wide copy number alterations detection in fresh frozen and matched FFPE samples using SNP 6.0 arrays. Genes Chromosomes Cancer (2008) 1.08

Successful amplification of degraded DNA for use with high-throughput SNP genotyping platforms. Hum Mutat (2008) 1.04

An efficient method for the assessment of DNA quality of archival microdissected specimens. Mod Pathol (2002) 1.01

High fidelity of whole-genome amplified DNA on high-density single nucleotide polymorphism arrays. Genomics (2008) 0.93

SNP-based chromosomal copy number ascertainment following multiple displacement whole-genome amplification. Biotechniques (2007) 0.93

Whole genome amplification for array comparative genomic hybridization using DNA extracted from formalin-fixed, paraffin-embedded histological sections. J Mol Diagn (2009) 0.85

Articles by these authors

Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res (2005) 7.13

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res (2010) 5.08

Modeling the percolation of annotation errors in a database of protein sequences. Bioinformatics (2002) 4.12

Detection of functional modules from protein interaction networks. Proteins (2004) 3.08

Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol (2005) 2.94

Genome-wide identification of genes likely to be involved in human genetic disease. Nucleic Acids Res (2004) 2.86

Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer (2008) 2.72

Comparative genomics of transcriptional control in the human malaria parasite Plasmodium falciparum. Genome Res (2004) 2.66

Evaluation of annotation strategies using an entire genome sequence. Bioinformatics (2003) 2.66

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell (2003) 2.65

Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol (2012) 2.59

Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 2.40

The balance of driving forces during genome evolution in prokaryotes. Genome Res (2003) 2.39

The net of life: reconstructing the microbial phylogenetic network. Genome Res (2005) 2.31

Protein families and TRIBES in genome sequence space. Nucleic Acids Res (2003) 2.27

BioLayout(Java): versatile network visualisation of structural and functional relationships. Appl Bioinformatics (2005) 2.26

Circulating microRNAs as novel biomarkers for platelet activation. Circ Res (2013) 2.22

Genome evolution reveals biochemical networks and functional modules. Proc Natl Acad Sci U S A (2003) 2.08

Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome. J Immunol (2007) 2.02

The phylogenetic extent of metabolic enzymes and pathways. Genome Res (2003) 1.92

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors. Eur J Nucl Med Mol Imaging (2014) 1.92

An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol (2004) 1.90

Patient's delay in oral cancer: A systematic review. Community Dent Oral Epidemiol (2006) 1.82

Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ Res (2013) 1.81

Major and minor salivary gland tumors. Crit Rev Oncol Hematol (2009) 1.77

COmplete GENome Tracking (COGENT): a flexible data environment for computational genomics. Bioinformatics (2003) 1.77

Myriads of protein families, and still counting. Genome Biol (2003) 1.75

Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet (2011) 1.72

Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol (2011) 1.70

Transcription regulation and environmental adaptation in bacteria. Trends Microbiol (2003) 1.63

Measuring genome conservation across taxa: divided strains and united kingdoms. Nucleic Acids Res (2005) 1.61

Areca nut use: an independent risk factor for oral cancer. BMJ (2002) 1.57

Betel-quid dependence domains and syndrome associated with betel-quid ingredients among chewers: an Asian multi-country evidence. Addiction (2014) 1.55

Facial reconstruction in the developing world: a complicated matter. Br J Oral Maxillofac Surg (2010) 1.48

Maté drinking and oral and oro-pharyngeal cancer: a systematic review and meta-analysis. Oral Oncol (2009) 1.48

Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res (2011) 1.47

Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy. Int J Oncol (2008) 1.42

TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene (2004) 1.41

Integrated media presentation in multidisciplinary head and neck oncology meetings. Eur Arch Otorhinolaryngol (2008) 1.38

Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation (2012) 1.36

MagicMatch--cross-referencing sequence identifiers across databases. Bioinformatics (2005) 1.34

Highly consistent patterns for inherited human diseases at the molecular level. Bioinformatics (2005) 1.33

Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J Clin Endocrinol Metab (2006) 1.31

An exponential core in the heart of the yeast protein interaction network. Mol Biol Evol (2004) 1.31

Structural and functional properties of genes involved in human cancer. BMC Genomics (2006) 1.29

Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol Gastrointest Liver Physiol (2008) 1.28

The phylogenetic diversity of eukaryotic transcription. Nucleic Acids Res (2003) 1.28

Sequence-based feature prediction and annotation of proteins. Genome Biol (2009) 1.28

Percolation of annotation errors through hierarchically structured protein sequence databases. Math Biosci (2005) 1.27

Genome coverage, literally speaking. The challenge of annotating 200 genomes with 4 million publications. EMBO Rep (2005) 1.25

Functional evolution of the yeast protein interaction network. Mol Biol Evol (2004) 1.25

Antibiotic prophylaxis of endocarditis: the rest of the world and NICE. J R Soc Med (2011) 1.24

Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med (2005) 1.23

GeneTRACE-reconstruction of gene content of ancestral species. Bioinformatics (2003) 1.23

Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med (2009) 1.20

Outcome of minimally invasive management of salivary calculi in 4,691 patients. Laryngoscope (2009) 1.20

Prognostic factors for keratocystic odontogenic tumor (odontogenic keratocyst): analysis of clinico-pathologic and immunohistochemical findings in cysts treated by enucleation. J Oral Pathol Med (2009) 1.19

Involvement of sphingolipids in apoptin-induced cell killing. Mol Ther (2006) 1.16

Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer (2011) 1.16

Areca (betel) nut chewing habit among high-school children in the Commonwealth of the Northern Mariana Islands (Micronesia). Bull World Health Organ (2005) 1.15

From genes to genomes: universal scale-invariant properties of microbial chromosome organisation. J Mol Biol (2003) 1.15

E1A activates transcription of p73 and Noxa to induce apoptosis. J Biol Chem (2004) 1.14

The impact of stomatological disease on oral health-related quality of life. Eur J Oral Sci (2003) 1.14

Consensus Report: 2nd European Workshop on Tobacco Use Prevention and Cessation for Oral Health Professionals. Int Dent J (2010) 1.12

Probabilistic annotation of protein sequences based on functional classifications. BMC Bioinformatics (2005) 1.12

Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 1.12

Patient delay for potentially malignant oral symptoms. Eur J Oral Sci (2008) 1.12

Barriers and triggers to seeking help for potentially malignant oral symptoms: implications for interventions. J Public Health Dent (2009) 1.12

Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus. J Oral Pathol Med (2010) 1.12

Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer (2014) 1.11

Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert. PLoS One (2010) 1.10

p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells. Neurosci Lett (2007) 1.08

Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer (2009) 1.08

Automated metabolic reconstruction for Methanococcus jannaschii. Archaea (2004) 1.07

Acid ceramidase inhibition: a novel target for cancer therapy. Front Biosci (2008) 1.07

Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors. Ann Surg Oncol (2008) 1.07

Illness and treatment beliefs in head and neck cancer: is Leventhal's common sense model a useful framework for determining changes in outcomes over time? J Psychosom Res (2007) 1.07

Beyond 100 genomes. Genome Biol (2003) 1.06

Population burden of betel quid abuse and its relation to oral premalignant disorders in South, Southeast, and East Asia: an Asian Betel-quid Consortium Study. Am J Public Health (2012) 1.05

Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev (2013) 1.03

Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ Res (2013) 1.02

The role of histopathological characteristics in distinguishing amalgam-associated oral lichenoid reactions and oral lichen planus. J Oral Pathol Med (2006) 1.02

Evaluation of tobacco use cessation (TUC) counselling in the dental office. Oral Health Prev Dent (2006) 1.02

Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. FEMS Microbiol Lett (2004) 1.01

The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood. PLoS One (2013) 1.01

Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res (2002) 1.00

Associations between quality of life, coping styles, optimism, and anxiety and depression in pretreatment patients with head and neck cancer. Head Neck (2011) 1.00

Genetic variation between Helicobacter pylori strains: gene acquisition or loss? Trends Microbiol (2002) 0.98

Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis. PLoS One (2013) 0.98

Development and preliminary validation of a new measure to assess satisfaction with information among head and neck cancer patients: the satisfaction with cancer information profile (SCIP). Head Neck (2006) 0.97

Oral lichenoid contact lesions to mercury and dental amalgam--a review. J Biomed Biotechnol (2012) 0.97

Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod Pathol (2012) 0.96

Octreotide LAR: safety and tolerability issues. Expert Opin Drug Saf (2009) 0.95

Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Oral Oncol (2010) 0.95

Efficacy of bovine bone mineral for alveolar augmentation: a human histologic study. Clin Oral Implants Res (2003) 0.95

Assessing the psychological predictors of benefit finding in patients with head and neck cancer. Psychooncology (2011) 0.94

ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63. Proc Natl Acad Sci U S A (2013) 0.94

Intraoral duct ligation without inclusion of the parasympathetic nerve supply induces rat submandibular gland atrophy. Int J Exp Pathol (2006) 0.93